PRMT5 and neoplasm: Previous research strongly suggests that PRMT5 is a tumor promoter, as it is significantly overexpressed in cancers such as colon, ovarian, kidney, lung, bladder, liver, pancreatic, breast, prostate, cervical, and skin cancers [34].